Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers

Background and Aims: Chronic diabetic foot ulcers pose a major problem because of associated limb threatening complications. The aim of the present study was to evaluate the efficacy of hyperbaric oxygen therapy (HBOT) as an adjuvant to standard therapy for treatment of diabetic foot ulcers. Materia...

Full description

Bibliographic Details
Main Authors: Atit Kumar, Usha Shukla, Tallamraju Prabhakar, Dhiraj Srivastava
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Anaesthesiology Clinical Pharmacology
Subjects:
Online Access:http://www.joacp.org/article.asp?issn=0970-9185;year=2020;volume=36;issue=2;spage=213;epage=218;aulast=Kumar
_version_ 1818792291421126656
author Atit Kumar
Usha Shukla
Tallamraju Prabhakar
Dhiraj Srivastava
author_facet Atit Kumar
Usha Shukla
Tallamraju Prabhakar
Dhiraj Srivastava
author_sort Atit Kumar
collection DOAJ
description Background and Aims: Chronic diabetic foot ulcers pose a major problem because of associated limb threatening complications. The aim of the present study was to evaluate the efficacy of hyperbaric oxygen therapy (HBOT) as an adjuvant to standard therapy for treatment of diabetic foot ulcers. Material and Methods: A total of 54 patients with diabetic foot ulcer of Wagner grade II–IV were recruited in this prospective, randomized, double blind study. Patients were randomized to receive HBOT along with standard therapy (group H; n = 28) or standard therapy alone (group S; n = 26). Patients were given 6 sessions per week for 6 weeks and followed up for 1 year. Outcomes were measured in terms of healing, and need for amputation, grafting or debridement. Parametric continuous variables were analyzed using Student unpaired t-test and categorical variables were analyzed using Chi square test. Results: The diabetic ulcers in 78% patients in Group H completely healed without any surgical intervention while no patient in group S healed without surgical intervention (P = 0.001). 2 patients in group H required distal amputation while in Group S, three patients underwent proximal amputation. Conclusion: The present study shows that hyperbaric oxygen therapy is a useful adjuvant to standard therapy and is a better treatment modality if combined with standard treatment rather than standard treatment alone for management of diabetic foot ulcers.
first_indexed 2024-12-18T15:24:55Z
format Article
id doaj.art-f199c0d556484e64876bd406e0120f95
institution Directory Open Access Journal
issn 0970-9185
language English
last_indexed 2024-12-18T15:24:55Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Anaesthesiology Clinical Pharmacology
spelling doaj.art-f199c0d556484e64876bd406e0120f952022-12-21T21:03:17ZengWolters Kluwer Medknow PublicationsJournal of Anaesthesiology Clinical Pharmacology0970-91852020-01-0136221321810.4103/joacp.JOACP_94_19Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcersAtit KumarUsha ShuklaTallamraju PrabhakarDhiraj SrivastavaBackground and Aims: Chronic diabetic foot ulcers pose a major problem because of associated limb threatening complications. The aim of the present study was to evaluate the efficacy of hyperbaric oxygen therapy (HBOT) as an adjuvant to standard therapy for treatment of diabetic foot ulcers. Material and Methods: A total of 54 patients with diabetic foot ulcer of Wagner grade II–IV were recruited in this prospective, randomized, double blind study. Patients were randomized to receive HBOT along with standard therapy (group H; n = 28) or standard therapy alone (group S; n = 26). Patients were given 6 sessions per week for 6 weeks and followed up for 1 year. Outcomes were measured in terms of healing, and need for amputation, grafting or debridement. Parametric continuous variables were analyzed using Student unpaired t-test and categorical variables were analyzed using Chi square test. Results: The diabetic ulcers in 78% patients in Group H completely healed without any surgical intervention while no patient in group S healed without surgical intervention (P = 0.001). 2 patients in group H required distal amputation while in Group S, three patients underwent proximal amputation. Conclusion: The present study shows that hyperbaric oxygen therapy is a useful adjuvant to standard therapy and is a better treatment modality if combined with standard treatment rather than standard treatment alone for management of diabetic foot ulcers.http://www.joacp.org/article.asp?issn=0970-9185;year=2020;volume=36;issue=2;spage=213;epage=218;aulast=Kumarfoot ulcer diabetichyperbaric oxygenationwound healing
spellingShingle Atit Kumar
Usha Shukla
Tallamraju Prabhakar
Dhiraj Srivastava
Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers
Journal of Anaesthesiology Clinical Pharmacology
foot ulcer diabetic
hyperbaric oxygenation
wound healing
title Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers
title_full Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers
title_fullStr Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers
title_full_unstemmed Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers
title_short Hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers
title_sort hyperbaric oxygen therapy as an adjuvant to standard therapy in the treatment of diabetic foot ulcers
topic foot ulcer diabetic
hyperbaric oxygenation
wound healing
url http://www.joacp.org/article.asp?issn=0970-9185;year=2020;volume=36;issue=2;spage=213;epage=218;aulast=Kumar
work_keys_str_mv AT atitkumar hyperbaricoxygentherapyasanadjuvanttostandardtherapyinthetreatmentofdiabeticfootulcers
AT ushashukla hyperbaricoxygentherapyasanadjuvanttostandardtherapyinthetreatmentofdiabeticfootulcers
AT tallamrajuprabhakar hyperbaricoxygentherapyasanadjuvanttostandardtherapyinthetreatmentofdiabeticfootulcers
AT dhirajsrivastava hyperbaricoxygentherapyasanadjuvanttostandardtherapyinthetreatmentofdiabeticfootulcers